Global Fairness in Drug Pricing Act

1. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   19 mai 2025 · IntroReferral

2. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   19 mai 2025 · IntroReferral

3. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   19 mai 2025 · IntroReferral

4. Introduced in House

   19 mai 2025 · IntroReferral

5. Introduced in House

   19 mai 2025 · IntroReferral

Cosponsors

• Republican:Rep. Barrett, Tom [R-MI-7]MI
• Democrat:Rep. Subramanyam, Suhas [D-VA-10]VA
• Republican:Rep. Greene, Marjorie Taylor [R-GA-14]GA
• Republican:Rep. Crane, Elijah [R-AZ-2]AZ
• Democrat:Rep. Kaptur, Marcy [D-OH-9]OH
• Republican:Rep. Biggs, Andy [R-AZ-5]AZ
• Republican:Rep. Luna, Anna Paulina [R-FL-13]FL